X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7520) 7520
Book Chapter (46) 46
Publication (29) 29
Book / eBook (22) 22
Dissertation (15) 15
Conference Proceeding (14) 14
Magazine Article (6) 6
Report (4) 4
Paper (3) 3
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pooled analysis (5677) 5677
humans (4967) 4967
female (3276) 3276
male (2573) 2573
middle aged (2220) 2220
oncology (2123) 2123
risk factors (2015) 2015
aged (2002) 2002
adult (1672) 1672
cancer (1393) 1393
risk (1105) 1105
epidemiology (914) 914
research (897) 897
public, environmental & occupational health (849) 849
treatment outcome (822) 822
analysis (812) 812
aged, 80 and over (792) 792
health aspects (696) 696
mortality (666) 666
case-control studies (647) 647
care and treatment (556) 556
incidence (542) 542
prognosis (522) 522
adolescent (519) 519
chemotherapy (497) 497
prospective studies (486) 486
smoking (486) 486
studies (484) 484
cohort studies (481) 481
young adult (477) 477
survival (476) 476
cardiac & cardiovascular systems (461) 461
prevalence (455) 455
women (452) 452
double-blind (444) 444
metaanalysis (443) 443
time factors (433) 433
efficacy (428) 428
animals (423) 423
medicine, general & internal (419) 419
follow-up studies (411) 411
abridged index medicus (408) 408
pharmacology & pharmacy (407) 407
association (396) 396
retrospective studies (395) 395
therapy (387) 387
risk-factors (386) 386
safety (382) 382
breast cancer (380) 380
risk assessment (379) 379
meta-analysis (378) 378
diet (372) 372
medicine & public health (372) 372
health risk assessment (369) 369
surgery (366) 366
child (364) 364
population (359) 359
age (353) 353
stroke (347) 347
clinical neurology (346) 346
united-states (344) 344
clinical trials (336) 336
odds ratio (329) 329
diagnosis (327) 327
breast-cancer (325) 325
body mass index (323) 323
age factors (318) 318
obesity (313) 313
patients (313) 313
prevention (313) 313
colorectal cancer (308) 308
cigarette-smoking (307) 307
medical research (298) 298
confidence intervals (296) 296
hematology (289) 289
oncology, experimental (282) 282
proportional hazards models (279) 279
body-mass index (277) 277
usage (271) 271
neoplasm staging (269) 269
tumors (269) 269
exposure (265) 265
diabetes (263) 263
cohort (262) 262
disease (260) 260
medicine (258) 258
internal medicine (254) 254
colorectal-cancer (253) 253
randomized controlled trials as topic (251) 251
public health (249) 249
drug therapy (248) 248
endocrinology & metabolism (239) 239
children (238) 238
regression analysis (238) 238
outcomes (237) 237
hematology, oncology and palliative medicine (233) 233
child, preschool (226) 226
genetic predisposition to disease (226) 226
adjuvant chemotherapy (225) 225
logistic models (225) 225
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7409) 7409
French (73) 73
German (71) 71
Spanish (40) 40
Korean (31) 31
Japanese (24) 24
Portuguese (12) 12
Italian (11) 11
Russian (7) 7
Polish (4) 4
Turkish (4) 4
Chinese (3) 3
Czech (2) 2
Icelandic (2) 2
Catalan (1) 1
Croatian (1) 1
Greek (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychological Methods, ISSN 1082-989X, 6/2009, Volume 14, Issue 2, pp. 81 - 100
Journal Article
International journal of epidemiology, ISSN 1464-3685, 2014, Volume 43, Issue 6, pp. 1929 - 1944
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 06/2012, Volume 175, Issue 11, pp. 1091 - 1099
Journal Article
Journal Article
Annals of oncology, ISSN 0923-7534, 2017, Volume 28, Issue 7, pp. 1631 - 1639
Background: Previous analysis of COMBI-d (NCT01584648) demonstrated improved progression-free survival (PFS... 
trametinib | melanoma | durable outcomes | BRAF | metastatic | dabrafenib | MULTICENTER | OPEN-LABEL | COMBINATION | TRIAL | MEK INHIBITION | ONCOLOGY | DOUBLE-BLIND | POOLED ANALYSIS | NIVOLUMAB | IPILIMUMAB | VEMURAFENIB | Skin Neoplasms - drug therapy | Oximes - pharmacokinetics | Oximes - adverse effects | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Oximes - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Imidazoles - pharmacokinetics | Protein Kinase Inhibitors - adverse effects | Pyridones - administration & dosage | Time Factors | Melanoma - genetics | Skin Neoplasms - mortality | Protein Kinase Inhibitors - pharmacokinetics | Skin Neoplasms - pathology | Double-Blind Method | Drug Administration Schedule | Pyridones - pharmacokinetics | Imidazoles - adverse effects | Pyrimidinones - adverse effects | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Disease Progression | Melanoma - secondary | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Pyrimidinones - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Skin Neoplasms - genetics | Biomarkers, Tumor - genetics | Pyrimidinones - administration & dosage | Mutation | Pyridones - adverse effects | Melanoma - mortality | Original
Journal Article
Lancet neurology, ISSN 1474-4422, 2014, Volume 13, Issue 6, pp. 567 - 574
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2014, Volume 133, Issue 5, pp. 1317 - 1329
Journal Article